Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies

Z Yu1, J B Schwartz, E T Sugita

  • 1Department of Clinical Pharmacology and Statistics, ALZA Corporation, Palo Alto, CA 94304, USA.

Biopharmaceutics & Drug Disposition
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: differences between the sexes and across the agespan.

The journal of nutrition, health & aging·2014
Same author

A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations.

The Journal of clinical endocrinology and metabolism·2014
Same author

Response to "CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers".

Clinical pharmacology and therapeutics·2013
Same author

Variability in free 25(OH) vitamin D levels in clinical populations.

The Journal of steroid biochemistry and molecular biology·2013
Same author

Association of CYP2C9*2 with bosentan-induced liver injury.

Clinical pharmacology and therapeutics·2013
Same author

Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

Clinical and experimental immunology·2012

Five numerical deconvolution methods were evaluated for pharmacokinetic and biopharmaceutic studies. The fixed step number equal step length method is simple and accurate for drug release and absorption analysis.

Area of Science:

  • Pharmacokinetics and Biopharmaceutics
  • Numerical Analysis
  • Computational Science

Background:

  • Accurate deconvolution is crucial for analyzing drug release and absorption kinetics.
  • Existing numerical methods may have limitations in accuracy and stability.
  • Simulated data analysis is a common approach to evaluate deconvolution techniques.

Purpose of the Study:

  • To propose and evaluate five numerical deconvolution methods for pharmacokinetic and biopharmaceutic applications.
  • To compare the performance of finite-difference and nonlinear regression deconvolution techniques.
  • To identify a simple, accurate, and stable deconvolution method for drug absorption and release studies.

Main Methods:

  • Implementation of four finite-difference and one nonlinear regression numerical deconvolution methods using IMSL/IDL.

Related Experiment Videos

  • Evaluation of methods using simulated drug release/absorption data with and without noise.
  • Comparison based on the superimposability of calculated cumulative drug profiles with theoretical data.

    • Main Results:

    • The fixed step number equal step length finite-difference method demonstrated simplicity and accuracy.
    • This method is suitable for pharmacokinetic and biopharmaceutic studies.
    • Nonlinear regression deconvolution offered enhanced accuracy and stability when an analytic function represented the drug input rate.

    Conclusions:

    • The fixed step number equal step length method is a reliable tool for pharmacokinetic and biopharmaceutic data analysis.
    • Nonlinear regression deconvolution provides superior results under specific conditions for drug input rate modeling.
    • Accurate deconvolution is essential for understanding drug disposition and optimizing therapeutic strategies.